Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
AARTIPHARM
AARTIPHARM

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM
BSE: 543748
Sector: Healthcare
Industry: Pharmaceuticals
823.65-5.1 (-0.62%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

46.3 / 100

Value Score

36.7 / 100

Price Momentum Score

81.3 / 100

QVM Score

56.9 / 100

Key Metrics

Market Cap
7468.86
P/E (TTM)
35.04
P/B
3.52
P/S (TTM)
3.79
EV/EBITDA
18.77
CAPE (5Y)
38.10
ROE (TTM)
8.49
ROCE (TTM)
11.19
ROA (TTM)
5.47
Avg 3Y ROE
12.04
Earnings 3Y CAGR
3.97
Sales 3Y CAGR
0.39
Sales 5Y CAGR
-
Debt/Equity
0.37
Consensus TP
740.00
Strong Buy %
-
Promoter Holding
39.66
Pledged %
11.98

Share Price

Track Aarti Pharmalabs Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -6.08 %
Low
782.0
High
879.0
1 Month returns: -12.39 %
Low
782.0
High
1,002.4
1 Year returns: -1.74 %
Low
583.8
High
1,002.4
3 Year CAGR: 29.22 %
Low
371.1
High
1,002.4
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Aarti Pharmalabs Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Aarti Pharmalabs Ltd. Shareholding Pattern

Quarterly breakdown of Aarti Pharmalabs Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Aarti Pharmalabs Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Aarti Pharmalabs Ltd.?
The current share price of Aarti Pharmalabs Ltd. is ₹ 823.65 as of 23 Oct 2026.
What is the market capitalisation of Aarti Pharmalabs Ltd.?
The market capitalisation of Aarti Pharmalabs Ltd. stands at ₹ 7,468.86 Cr.
What is the PE ratio of Aarti Pharmalabs Ltd.?
The Price-to-Earnings (PE) ratio of Aarti Pharmalabs Ltd. is 35.04 as of the latest trailing twelve months data.
What is the ROE and ROCE of Aarti Pharmalabs Ltd.?
Aarti Pharmalabs Ltd. has a Return on Equity (ROE) of 8.49% and a Return on Capital Employed (ROCE) of 11.19% as per the latest financial reports.
What is the 52-week high and low of Aarti Pharmalabs Ltd.?
The 52-week high of Aarti Pharmalabs Ltd. is - and the 52-week low is -.
What is the dividend yield of Aarti Pharmalabs Ltd.?
The dividend yield of Aarti Pharmalabs Ltd. is 0.42% based on the current market price.
What is the FII and DII holding in Aarti Pharmalabs Ltd.?
Foreign Institutional Investors (FII) hold 8.16%, Domestic Institutional Investors (DII) hold 5.35% and retail/public investors hold 39.72% of Aarti Pharmalabs Ltd. shares.
What sector does Aarti Pharmalabs Ltd. belong to?
Aarti Pharmalabs Ltd. operates in the Healthcare sector.
What is the beta of Aarti Pharmalabs Ltd.?
The beta of Aarti Pharmalabs Ltd. is 1.22, indicating its price volatility relative to the broader market. Over the past 1 year, Aarti Pharmalabs Ltd. has delivered an absolute return of -1.55%.
What is the RSI of Aarti Pharmalabs Ltd.?
The 14-day Relative Strength Index (RSI) of Aarti Pharmalabs Ltd. is 41.07, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.